Literature DB >> 19945312

A MicroRNA expression profile defining the invasive bladder tumor phenotype.

Matthew F Wszolek1, Kimberly M Rieger-Christ, Patrick A Kenney, Justin J Gould, Brasil Silva Neto, Amanda K Lavoie, Tanya Logvinenko, John A Libertino, Ian C Summerhayes.   

Abstract

OBJECTIVE: The purpose of this study was to identify microRNA (miRNA) involved in the transition between the noninvasive and invasive urothelial carcinoma of the bladder (UCB) phenotype.
METHODS: Differential expression of miRNA was identified in a microarray format between noninvasive and invasive UCB cell lines and confirmed using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) within this cell panel. Normalization of qRT-PCR with miR-222 was established from the microarray data and validated within a panel of 57 UCB tumors (26 noninvasive lesions (Ta/G1) and 31 invasive lesions (T2-T4). Pre-miR constructs were transfected into appropriate UCB cell lines to establish a change in invasive potential.
RESULTS: Differential expression of miRNAs was identified from microarray analysis and included reduced expression associated with miR-30b, miR-31, miR-141, miR-200a, miR-200b, miR-200c, miR-205, miR-21 in invasive lesions and elevated miR-99a in noninvasive UCB lesions. Reduced invasion potential was recorded in UM-UC-3, following pre-miR transfection, in all UCB cell lines with the exception of UM-UC-3/miR-30b transfectants. Our results identify a panel of miRNA modulated and expressed in invasive UCB tumors and demonstrates a role for them in the invasive phenotype.
CONCLUSIONS: The diagnostic test, based on the three most discriminatory miRNAs in our panel (miR-200c, miR-141, and miR-30b), showed a sensitivity of 100% and a specificity of 96.2%. Such a panel of miRNAs has the potential to identify invasive bladder tumors misclassified in pathologic assessment of bladder biopsy specimens.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945312     DOI: 10.1016/j.urolonc.2009.08.024

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  66 in total

1.  MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.

Authors:  Mick D Edmonds; Kelli L Boyd; Tamara Moyo; Ramkrishna Mitra; Robert Duszynski; Maria Pia Arrate; Xi Chen; Zhongming Zhao; Timothy S Blackwell; Thomas Andl; Christine M Eischen
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

2.  Population differences in microRNA expression and biological implications.

Authors:  R Stephanie Huang; Eric R Gamazon; Dana Ziliak; Yujia Wen; Hae Kyung Im; Wei Zhang; Claudia Wing; Shiwei Duan; Wasim K Bleibel; Nancy J Cox; M Eileen Dolan
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

Review 3.  The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer.

Authors:  Stephanie B Greene; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  RNA Biol       Date:  2010-05-21       Impact factor: 4.652

4.  Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.

Authors:  Christina Michailidi; Masamichi Hayashi; Sayantan Datta; Tanusree Sen; Kaitlyn Zenner; Oluwadamilola Oladeru; Mariana Brait; Evgeny Izumchenko; Alexander Baras; Christopher VandenBussche; Maria Argos; Trinity J Bivalacqua; Habibul Ahsan; Noah M Hahn; George J Netto; David Sidransky; Mohammad Obaidul Hoque
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-13

5.  Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.

Authors:  Zhenqiang Fang; Wei Dai; Xiangwei Wang; Wei Chen; Chongxin Shen; Gang Ye; Longkun Li
Journal:  Tumour Biol       Date:  2015-12-29

6.  Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis.

Authors:  Mingxia Ding; Yi Li; Haifeng Wang; Yongchang Lv; Jianwei Liang; Jiansong Wang; Chong Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.

Authors:  Nouha Setti Boubaker; Aymone Gurtner; Nesrine Trabelsi; Isabella Manni; Haroun Ayed; Ahmed Saadi; Zeineb Naimi; Meriem Ksontini; Mouna Ayadi; Ahlem Blel; Soumaya Rammeh; Mohamed Chebil; Giulia Piaggio; Slah Ouerhani
Journal:  Mol Biol Rep       Date:  2020-10-31       Impact factor: 2.316

8.  MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells.

Authors:  Zhiwei Zhong; Zhuo Dong; Lihua Yang; Xiaoqiang Chen; Zhaohui Gong
Journal:  Tumour Biol       Date:  2013-03-29

9.  Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells.

Authors:  Chao-Jie Wang; Johannes Stratmann; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

10.  MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.

Authors:  Hirosha Geekiyanage; Evanthia Galanis
Journal:  Mol Oncol       Date:  2016-07-28       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.